PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Choroid Diseases D015862 2 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Mor A et al. Inhibitory effect of farnesylthiosalicylic acid on mediators release by mast cells: preferential inhibition of prostaglandin D(2) and tumor necrosis factor-α release. 2011 Inflammation pmid:20706780
Balzar S et al. Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. 2011 Am. J. Respir. Crit. Care Med. pmid:20813890
Mathurin K et al. An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production. 2011 J. Biol. Chem. pmid:21112970
Wingard CJ et al. Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. 2011 Nanotoxicology pmid:21043986
Joachim A and Ruttkowski B Prostaglandin D(2) synthesis in Oesophagostomum dentatum is mediated by cytosolic glutathione S-transferase. 2011 Exp. Parasitol. pmid:21056037
Lotz C et al. Peroxisome-proliferator-activated receptor γ mediates the second window of anaesthetic-induced preconditioning. 2011 Exp. Physiol. pmid:21123361
Tsujita T et al. Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish. 2011 Genes Cells pmid:21143560
Neri T et al. Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. 2011 Eur. Respir. J. pmid:21148223
Kumar VB et al. Angiogenic effect of laminin involves modulation of cyclooxygenase-2 and prostaglandin levels. 2011 Exp. Biol. Med. (Maywood) pmid:21148739
Maekawa N et al. High-performance affinity purification for identification of 15-deoxy-Δ 12,14 -PGJ₂ interacting factors using magnetic nanobeads. 2011 Biomed. Chromatogr. pmid:21374648
Kane CJ et al. Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists. 2011 Brain Behav. Immun. pmid:21376806
Arima M and Fukuda T Prostaglandin Dâ‚‚ and T(H)2 inflammation in the pathogenesis of bronchial asthma. 2011 Korean J. Intern. Med. pmid:21437156
Martínez-Gras I et al. The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia. 2011 Schizophr. Res. pmid:21334179
Zhao J et al. Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. 2011 J. Clin. Invest. pmid:22105170
Chbicheb S et al. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells. 2011 Biochem. Pharmacol. pmid:21338579
Braciale TJ and Kim TS Slowing down with age: lung DCs do it too. 2011 J. Clin. Invest. pmid:22105176
Qiu Z et al. Cough reflex sensitivity and airway inflammation in patients with chronic cough due to non-acid gastro-oesophageal reflux. 2011 Respirology pmid:21342332
Wang JJ and Mak OT Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells. 2011 Prostaglandins Other Lipid Mediat. pmid:21396480
Murata T et al. Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:22106279
Yamamoto Y et al. Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane. 2011 PLoS ONE pmid:21445266
Mackay GA and Stewart AG R2D(2) for C(4)Eo: an 'alliance' of PGD(2) receptors is required for LTC(4) production by human eosinophils. 2011 Br. J. Pharmacol. pmid:21426314
Huang ZL et al. The role of adenosine in the regulation of sleep. 2011 Curr Top Med Chem pmid:21401496
Osanai T and Okumura K Lipocalin-type PGD synthase as a novel biomarker for coronary vasospasm. 2011 Circ. J. pmid:21378446
Du H et al. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. 2011 Br. J. Pharmacol. pmid:21501147
Varma D et al. Comparison of UHPLC and HPLC methods for the assay of prostanoids: "are the methods equivalent in terms of accuracy and precision?". 2011 Bioanalysis pmid:21510759
Kamauchi S and Urade Y [Hematopoietic prostaglandin D synthase inhibitors for the treatment of duchenne muscular dystrophy]. 2011 Brain Nerve pmid:22068479
Flachs P et al. Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. 2011 Diabetologia pmid:21779874
Raman P et al. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. 2011 Mol. Pharmacol. pmid:21511917
Leamy AW et al. Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. 2011 Neurosci. Lett. pmid:21855605
Lin TH et al. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts. 2011 J. Cell. Physiol. pmid:21344384
Zheng S et al. Novel biphasic role of LipoxinA(4) on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts. 2011 Mediators Inflamm. pmid:21765620
Hernandez JM and Janssen LJ Thromboxane prostanoid receptor activation amplifies airway stretch-activated contractions assessed in perfused intact bovine bronchial segments. 2011 J. Pharmacol. Exp. Ther. pmid:21768224
Tanaka A et al. Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2. 2011 Am. J. Physiol., Cell Physiol. pmid:21865589
Kitz K et al. 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species. 2011 Free Radic. Biol. Med. pmid:21236332
Hossain MS et al. Development of enzyme-linked immunosorbent assay for Δ12-prostaglandin J2 and its application to the measurement of the endogenous product generated by cultured adipocytes during the maturation phase. 2011 Prostaglandins Other Lipid Mediat. pmid:21237281
Aung G et al. Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. 2011 Immunology pmid:21214543
Chowdhury AA et al. Sustained expression of lipocalin-type prostaglandin D synthase in the antisense direction positively regulates adipogenesis in cloned cultured preadipocytes. 2011 Biochem. Biophys. Res. Commun. pmid:21726533
Hovsepian E et al. Modulation of inflammatory response and parasitism by 15-Deoxy-Δ(12,14) prostaglandin J(2) in Trypanosoma cruzi-infected cardiomyocytes. 2011 Int. J. Parasitol. pmid:21215746
Song NY et al. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells. 2011 Chem. Res. Toxicol. pmid:21728338
Lotz C et al. Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo. 2011 Exp. Biol. Med. (Maywood) pmid:21163821
Charles RL et al. Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation. 2011 Circ. Res. pmid:21164107
Eguchi M et al. Lipopolysaccharide induces proinflammatory cytokines and chemokines in experimental otitis media through the prostaglandin D2 receptor (DP)-dependent pathway. 2011 Clin. Exp. Immunol. pmid:21166666
Oh YC et al. Anti-allergic effects of sinomenine by inhibition of prostaglandin Dâ‚‚ and leukotriene Câ‚„ in mouse bone marrow-derived mast cells. 2011 Immunopharmacol Immunotoxicol pmid:21080779
Cichocka-Jarosz E et al. Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children. 2011 J Investig Allergol Clin Immunol pmid:21721371
Nabe T et al. Inhibition of hematopoietic prostaglandin D synthase improves allergic nasal blockage in guinea pigs. 2011 Prostaglandins Other Lipid Mediat. pmid:21601002
Joos H et al. Single impact trauma in human early-stage osteoarthritic cartilage: implication of prostaglandin D2 but no additive effect of IL-1β on cell survival. 2011 Int. J. Mol. Med. pmid:21567074
Shao Z et al. Choroidal involution is a key component of oxygen-induced retinopathy. 2011 Invest. Ophthalmol. Vis. Sci. pmid:21546530
Ji Y et al. Nutrient-induced inflammation in the intestine. 2011 Curr Opin Clin Nutr Metab Care pmid:21587069
Jakob S and Lovell-Badge R Sex determination and the control of Sox9 expression in mammals. 2011 FEBS J. pmid:21281448
Hardy KD et al. Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo. 2011 J. Lipid Res. pmid:20944061
Matsushima Y et al. Distinct roles of prostaglandin D2 receptors in chronic skin inflammation. 2011 Mol. Immunol. pmid:21943706
Shinozawa T et al. Tetranor PGDM analyses for the amyotrophic lateral sclerosis: positive and simple diagnosis and evaluation of drug effect. 2011 Biochem. Biophys. Res. Commun. pmid:22027143
Chang MC et al. Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production. 2011 Atherosclerosis pmid:21993412
de Jong E et al. Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC. 2011 PLoS ONE pmid:21957481
Jin M et al. Anti-inflammatory activity of 6-hydroxy-2,7-dimethoxy-1,4-henanthraquinone from tuberous roots of yam (Dioscorea batatas) through inhibition of prostaglandin Dâ‚‚ and leukotriene Câ‚„ production in mouse bone marrow-derived mast cells. 2011 Arch. Pharm. Res. pmid:21975811
Urade Y and Hayaishi O Prostaglandin D2 and sleep/wake regulation. 2011 Sleep Med Rev pmid:22024172
Wan CJ et al. [PPARgamma agonists against respiratory syncytial virus infection in vitro study]. 2011 Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi pmid:22734242
Wang P et al. Response of chondrocytes to shear stress: antagonistic effects of the binding partners Toll-like receptor 4 and caveolin-1. 2011 FASEB J. pmid:21715681
Ahmed SR et al. Prostaglandin D2 regulates CD4+ memory T cell trafficking across blood vascular endothelium and primes these cells for clearance across lymphatic endothelium. 2011 J. Immunol. pmid:21715691
Yu R et al. Competitive enzymatic interactions determine the relative amounts of prostaglandins E2 and D2. 2011 J. Pharmacol. Exp. Ther. pmid:21865441
Koyama J et al. Simultaneous determination of histamine and prostaglandin D2 using an LC-ESI-MS/MS method with positive/negative ion-switching ionization modes: application to the study of anti-allergic flavonoids on the degranulation of KU812 cells. 2011 Anal Bioanal Chem pmid:21725829
Galvão Nascimento N et al. Contribution of mast cells to the oedema induced by Bothrops moojeni snake venom and a pharmacological assessment of the inflammatory mediators involved. 2010 Feb-Mar Toxicon pmid:19703484
Reddy RC and Standiford TJ Nrf2 and PPAR{gamma}: PPARtnering against oxidant-induced lung injury. 2010 Am. J. Respir. Crit. Care Med. pmid:20634499
Ahmad AS et al. Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice. 2010 Age (Dordr) pmid:20640551
Shah S et al. Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia. 2010 Int. J. Clin. Pract. pmid:20518948
Genovese A et al. Human cardiac mast cells in anaphylaxis. 2010 Chem Immunol Allergy pmid:20519884
Diers AR et al. Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy. 2010 Biochem. J. pmid:20536428
Vong L et al. A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20547854
Lehmann GM et al. Novel anti-adipogenic activity produced by human fibroblasts. 2010 Am. J. Physiol., Cell Physiol. pmid:20554910
Schuligoi R et al. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases. 2010 Pharmacology pmid:20559016
Kaur S et al. Induction of prostaglandin D2 through the p38 MAPK pathway is responsible for the antipruritic activity of sertaconazole nitrate. 2010 J. Invest. Dermatol. pmid:20505747
Rodrigues WF et al. 15d-PGJ(2) modulates acute immune responses to Trypanosoma cruzi infection. 2010 Mem. Inst. Oswaldo Cruz pmid:20428671
Blancou P and Anegon I Editorial: Heme oxygenase-1 and dendritic cells: what else? 2010 J. Leukoc. Biol. pmid:20123679
Nørregaard R et al. Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissue. 2010 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:20147610
Dionne S et al. PPARgamma ligand 15-deoxy-delta 12,14-prostaglandin J2 sensitizes human colon carcinoma cells to TWEAK-induced apoptosis. 2010 Anticancer Res. pmid:20150631
Zhu F et al. Prostaglandin (PG)D(2) and 15-deoxy-Delta(12,14)-PGJ(2), but not PGE(2), mediate shear-induced chondrocyte apoptosis via protein kinase A-dependent regulation of polo-like kinases. 2010 Cell Death Differ. pmid:20150912
Templeton DJ et al. Purification of reversibly oxidized proteins (PROP) reveals a redox switch controlling p38 MAP kinase activity. 2010 PLoS ONE pmid:21085594
Hatanaka M et al. 15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells. 2010 J. Pharmacol. Sci. pmid:20424389
Zhang F et al. Peroxisome proliferator-activated receptor-gamma agonists suppress iNOS expression induced by LPS in rat primary Schwann cells. 2010 J. Neuroimmunol. pmid:19942298
Zorrilla S et al. Selective binding of the fluorescent dye 1-anilinonaphthalene-8-sulfonic acid to peroxisome proliferator-activated receptor gamma allows ligand identification and characterization. 2010 Anal. Biochem. pmid:20025845
Maggiora M et al. Involvement of PPARα and PPARγ in apoptosis and proliferation of human hepatocarcinoma HepG2 cells. 2010 Cell Biochem. Funct. pmid:20862655
Uehara Y [Prostaglandin D2 and related substances]. 2010 Nippon Rinsho pmid:20960740
Hanks BC et al. Evaluation of anti-inflammatory and chondroprotective effects of peroxisome proliferator-activated receptor gamma agonists in cartilage and synovial explants from dogs. 2010 Am. J. Vet. Res. pmid:20919899
Kim NJ et al. Concise and enantioselective total synthesis of 15-deoxy-Δ-(12,14)-prostaglandin J(2). 2010 J. Org. Chem. pmid:20929274
Pérez-Nievas BG et al. Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated. 2010 J Neuroinflammation pmid:20929574
Li H et al. Serum amyloid A activates peroxisome proliferator-activated receptor γ through extracellularly regulated kinase 1/2 and COX-2 expression in hepatocytes. 2010 Biochemistry pmid:20853849
Bancos S et al. Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-Delta(12,14)-prostaglandin J(2) requires Nrf2. 2010 Cell. Immunol. pmid:20064636
Pacienza N et al. 15-deoxy-Delta(12,14)-PGJ(2) induces cell cycle arrest and apoptosis of haematopoietic progenitors. 2010 Br. J. Haematol. pmid:19764987
Oh YC et al. Anti-allergic activity of a platycodon root ethanol extract. 2010 Int J Mol Sci pmid:20717534
Cerrato S et al. Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells. 2010 Vet. Immunol. Immunopathol. pmid:19625089
Biburger M et al. Pivotal Advance: Heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity. 2010 J. Leukoc. Biol. pmid:19797297
Toaldo C et al. PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells. 2010 J. Cell. Mol. Med. pmid:19912441
Diers AR et al. Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms. 2010 Biochem. J. pmid:19916962
Morgenweck J et al. Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. 2010 Neuropharmacology pmid:19891980
Liu JY et al. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. 2010 Biochem. Pharmacol. pmid:19896470
Shimura C et al. Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin. 2010 Am. J. Pathol. pmid:20008150
Yamaguchi S et al. Delta12-prostaglandin J2 as a product and ligand of human serum albumin: formation of an unusual covalent adduct at His146. 2010 J. Am. Chem. Soc. pmid:20014793
Lin TH et al. Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. 2010 J. Cell. Physiol. pmid:20020468
Hovsepian E et al. 15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells. 2010 Shock pmid:19997048
Théoleyre S et al. HtrA3 is regulated by 15-deoxy-Delta12,14-prostaglandin J2 independently of PPARgamma in clear cell renal cell carcinomas. 2010 Biochem. Biophys. Res. Commun. pmid:19951697